RNA therapeutics comprise a rapidly expanding category of drugs that will change the standard of care for many diseases and actualize personalized medicine. These drugs are cost effective, relatively ...
The global oligonucleotide CDMO market is poised for growth driven by the rising clinical pipeline of RNA-based therapies, increased mRNA therapeutic adoption, and biotech firms outsourcing to reduce ...
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key ...
This report aims to provide detailed insights into the Oligonucleotide Synthesis Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, ...
The 4-year deal is a big one for GSK, which has three oligo drug candidates in Phase 2 studies for hepatitis B. It’s even bigger for Wave. And it’s just one of several recent pacts highlighting the ...
Avidity Biosciences has advanced a first antibody–oligonucleotide conjugate (AOC) into a phase I trial. Its AOC 1001 uses an antibody to carry an siRNA payload to muscle cells, for a rare muscle ...
The Agilent SurePrint Oligonucleotide Library Synthesis platform delivers advanced and reliable array-based DNA synthesis. Agilent have harnessed their SurePrint platform to refine the DNA printing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results